Director/PDMR Shareholding

Director/PDMR Shareholding

Director/PDMR Shareholding

Director/PDMR Shareholding


Released: 05/01/2011

5 January 2011 BIOCOMPATIBLES INTERNATIONAL PLC (the `Company' or `Biocompatibles') BIOCOMPATIBLES INTERNATIONAL PLC SHARE INCENTIVE PLAN PURCHASE OF PARTNERSHIP SHARES AND AWARDS OF MATCHING SHARES

Biocompatibles International plc announces that on 4 January 2011the following executive directors purchased ordinary shares of 21 53/94 pence at a cost of 389.7 pence per share as "partnership shares" under the all-employee Biocompatibles International Share Incentive Plan as summarised below:

Executive Director Number of shares acquired Crispin Simon 32 Ian Ardill 32 Peter Stratford 32 John Sylvester 32

The above transactions were undertaken by the trustee of the Biocompatibles International Share Incentive Plan, a UK registered company, on behalf of the above individuals and the shares purchased on the London Stock Exchange.

In connection with the above purchases on the same date the executive directors were conditionally awarded ordinary shares of 21 53/94 pence as "matching shares" under the all employee Biocompatibles International Share Incentive Plan as summarised below: Executive Director Number of shares awarded as "matching shares" Crispin Simon 64 Ian Ardill 64 Peter Stratford 64 John Sylvester 64

The risk of forfeiture attached to the matching shares will normally be removed on the third anniversary of allocation subject to continued employment and the retention of the Partnership shares in connection with which they were awarded.

No consideration was paid by the grantees for the award of the matching shares and no consideration is due on the release of on the matching shares.

BIOCOMPATIBLES INTERNATIONAL PLC SHARE INCENTIVE PLAN VESTING OF AWARDS OF MATCHING SHARES

Biocompatibles International plc announces that on 31 December 2010 the following executive directors became unconditionally entitled to the following number of ordinary shares of 21 53/94 pence under the all-employee Biocompatibles International Share Incentive Plan ("SIP") as summarised below:

Executive Director Number of shares vesting under SIP Crispin Simon 204 Ian Ardill 204 Peter Stratford 204 John Sylvester 202

The shares so vesting under awards of "matching shares" awarded under the SIP on 31 December 2007.

No consideration was paid by the individual for the maturity of their "matching shares".

The above notifications are made in accordance with DTR 3.1.4R(1).

Biocompatibles International plc was notified by the above individuals of the above transactions on 04 January 2011.

- ends - Contact: Biocompatibles Tel: +44 (0)1257 732732 Ian Ardill, Finance Director

Sari Evetts, Assistant Company Secretary

Dealing Disclosure Requirements

Following the announcement made on Monday, 20 September 2010 that the Company is in an offer period for the purposes of the Takeover Code, the Company is required to restate the following:

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any paper offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any paper offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any paper offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a paper offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any paper offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any paper offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a paper offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129.

vendor

Back to press releases